These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 358918)

  • 1. Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids.
    Inoue S; Ohue T; Yamagishi J; Nakamura S; Shimizu M
    Antimicrob Agents Chemother; 1978 Aug; 14(2):240-5. PubMed ID: 358918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibacterial activity of pipemidic acid].
    Torosantucci A; Cialdea L; Calabrò AM; Fillini G
    Ann Ist Super Sanita; 1982; 18(3):467-70. PubMed ID: 7187832
    [No Abstract]   [Full Text] [Related]  

  • 3. New nalidixic acid resistance mutations related to deoxyribonucleic acid gyrase activity.
    Yamagishi J; Furutani Y; Inoue S; Ohue T; Nakamura S; Shimizu M
    J Bacteriol; 1981 Nov; 148(2):450-8. PubMed ID: 6271730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation affecting resistance of Escherichia coli K12 to nalidixic acid.
    Hrebenda J; Heleszko H; Brzostek K; Bielecki J
    J Gen Microbiol; 1985 Sep; 131(9):2285-92. PubMed ID: 3906038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of beta-lactam antibiotics: mapping of chromosomal genes.
    Rella M; Haas D
    Antimicrob Agents Chemother; 1982 Aug; 22(2):242-9. PubMed ID: 6821455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibacterial in-vitro activity of pipemidic acid and nalidixic acid (author's transl)].
    Peters G; Freiesleben H; Marre R; Metz H; Tannenberg H; Pulverer G
    Dtsch Med Wochenschr; 1979 Jun; 104(26):946-8. PubMed ID: 110574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies.
    Hane MW; Wood TH
    J Bacteriol; 1969 Jul; 99(1):238-41. PubMed ID: 4895844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activity of pipemidic acid and piromidic acid against Escherichia coli in static culture and in conditions stimulating the treatment of bacterial cystitis.
    Greenwood D
    J Appl Bacteriol; 1978 Apr; 44(2):191-7. PubMed ID: 346547
    [No Abstract]   [Full Text] [Related]  

  • 9. Cross resistance of quinolone derivatives in gram-negative bacteria.
    Barba D; Pennucci C; Esposito S; Galante D
    Chemioterapia; 1985 Apr; 4(2):192-6. PubMed ID: 3159488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of beta-hydroxy-piromidic acid against Staphylococcus aureus and enterobacteriaceae.
    García-Rodriguez JA; Gómez-García AC; Rodrigo N; Sáenz MC
    J Antimicrob Chemother; 1982 Jun; 9(6):493-5. PubMed ID: 7107550
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative bacteriologic in vitro studies with pipemidic acid and nalidixic acid].
    Grimm H
    Med Welt; 1980 Aug; 31(33):1189-91. PubMed ID: 7421555
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.
    Muytjens HL; van der Ros-van de Repe J; van Veldhuizen G
    Antimicrob Agents Chemother; 1983 Aug; 24(2):302-4. PubMed ID: 6227281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanism of action of nalidixic acid.
    Bourguignon GJ; Levitt M; Sternglanz R
    Antimicrob Agents Chemother; 1973 Oct; 4(4):479-86. PubMed ID: 4208771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of ofloxacin, norfloxacin, nalidixic acid, pyromidic acid and pipemidic acid on human gamma-interferon production and blastogenesis.
    De Simone C; Baldinelli L; Ferrazzi M; De Santis S; Pugnaloni L; Sorice F
    J Antimicrob Chemother; 1986 Jun; 17(6):811-4. PubMed ID: 3090010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nalidixic acid, pipemidic acid and cinoxacin on chondrocyte metabolism in explants of articular cartilage.
    Brand HS; van Kampen GP; van der Korst JK
    Clin Exp Rheumatol; 1990; 8(4):393-5. PubMed ID: 2397627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli.
    Yamagishi J; Yoshida H; Yamayoshi M; Nakamura S
    Mol Gen Genet; 1986 Sep; 204(3):367-73. PubMed ID: 3020376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicological studies on pipemidic acid. V. Effect on diarthrodial joints of experimental animals.
    Tatsumi H; Senda H; Yatera S; Takemoto Y; Yamayoshi M; Ohnishi K
    J Toxicol Sci; 1978 Nov; 3(4):357-67. PubMed ID: 105148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of conjugal transfer of R plasmids by pipemidic acid and related compounds.
    Nakamura S; Inoue S; Shimizu M; Iyobe S; Mitsuhashi S
    Antimicrob Agents Chemother; 1976 Nov; 10(5):779-85. PubMed ID: 827237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of recombination-deficient mutants of Escherichia coli during incubation with nalidixic acid.
    McDaniel LS; Rogers LH; Hill WE
    J Bacteriol; 1978 Jun; 134(3):1195-8. PubMed ID: 350844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of norfloxacin in synthetic media and human urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
    Shah PM; Ottnad-Walz M; Stille W
    Methods Find Exp Clin Pharmacol; 1983 Dec; 5(10):731-4. PubMed ID: 6231438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.